Heterogeneous regulatory changes in cell surface membrane receptors coupled to a positive inotropic response in the failing human heart
The failing human ventricular myocardium undergoes heterogeneous changes at the receptor level that have some impact on the ability of the failing myocardium to respond to inotropic stimuli. In the failing human ventricular myocardium the β l-adrenergic receptor is profoundly down-regulated, the β 2-adrenergic receptor is only slightly decreased, α l-adrenergic receptors are unchanged and VIP receptors appear to be increased in density or affinity. These changes have implications for therapeutic strategies for heart failure and for the natural history and pathogenesis of heart muscle disease.
KeywordsAdenylate Cyclase Vasoactive Intestinal Peptide Human Heart Creatine Kinase Activity Vasoactive Intestinal Peptide Receptor
Unable to display preview. Download preview PDF.
- 5.Bristow MR, Laser JA, Ginsburg R, Minobe W (1985) ßs and ß2 receptors are coupled to adenylate cyclase in human ventricular myocardium. Clin Res 33(2):171AGoogle Scholar
- 6.Bristow MR, Minobe W, Rasmussen R (1985) Differential regulation of alpha and beta-adrenergic receptors in the failing human heart. Circulation [Suppl III] 72: 1315Google Scholar
- 10.Ginsburg R, Bristow MR, Billingham ME, Stinson EB, Schroeder JS, Harrison DC (1983) Study of the normal and failing isolated human heart: Decreased response of failing heart to isoproterenol. Am Heart J 106: 535–540Google Scholar
- 11.Hershberger RE, Bristow MR (1986) Failing human left ventricular myocardium is supersensitive to vasoactive intestinal peptide. Clin Res 34 (2): 630AGoogle Scholar
- 15.Taton G, Chatelain P, Delhaye M, Camus JC, De Neef P, Waelbroeck M, Tatemoto K, Robberecht P, Christophe J (1982) Vasoactive intestinal peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide ( PHI) stimulate adenylate cyclase activity in human heart membranes. Peptides 3: 897–900PubMedCrossRefGoogle Scholar